Johnson & Johnson Launches Tecnis PureSee Presbyopia-Correcting IOL in EMEA

Johnson & Johnson MedTech announced that its Tecnis PureSee presbyopia-correcting IOL is now available in Europe, the Middle East, and Africa (EMEA). The Tecnis PureSee IOL features a proprietary, purely refractive design that delivers uninterrupted, high-quality, vision with high best-in-category contrast and low-light performance, comparable to a monofocal IOL, according to J&J. [1,2,3,4]

“Cataract surgery is the number one surgery performed globally, with 28 million procedures each year. But only 10-15% of patients are getting advanced optical IOLs specifically designed for astigmatism and presbyopia,” Jacqueline Henderson, President Vision, EMEA, Johnson & Johnson, said in a company news release. “Today, we’re proud to launch the Tecnis PureSee IOL, giving surgeons and patients the choice of a premium IOL that combines clarity of vision and reduced visual symptoms.”

With its purely refractive design, the Tecnis PureSee IOL is designed to ensure surgeons’ ease of use in providing high tolerance to refractive error. The Tecnis PureSee IOL offers important benefits to both surgeons and their patients, including:

• Uninterrupted high-quality vision, with excellent distance and intermediate vision, as well as functional near vision for increased spectacle independence[2,3]
• A dysphotopsia profile that is comparable to a monofocal IOL in frequency, bothersome and difficulty levels, which means little to no visual symptoms, such as halos, glares, and starbursts [3,12]

References:

1. DOF2023CT4014 – MTF of the TECNIS PureSee™ IOL. 28 March 2023.
2. DOF2023CT4016 – Simulated VA of the TECNIS PureSee™ IOL compared to TECNIS Eyhance™ and TECNIS™ 1-Piece IOLs. 29 March 2023.
3. Bala C, et al. Superior intermediate and uncompromised distance quality of vision with a purely refractive extended depth of focus IOL. Abstract ESCRS Vienna 2023. REF2023CT4128.
4. DOF2023CT4025 – MTF of the TECNIS PureSee™ IOL and other lens models in low-light conditions. 4 April 2023.
5. Bala C, et al. Six-month visual performance outcomes of a purely refractive extended depth of focus intraocular lens. Abstract ESCRS Vienna 2023. REF2023CT4127.
6. Black D, et al. Clinical evaluation of tolerance to residual refractive errors following implantation with a refractive extended depth of focus (EDF) IOL. Abstract ESCRS Vienna 2023. REF2023CT4129.
7. TECNIS PureSee™ IOL, Model ZEN00V – DfU INT – Z311973, current revision.
8. DOF2023CT4012 – Photic phenomena evaluation of the TECNIS PureSee™ IOL using natural images. 29 March 2023.  
9. University of Michigan – Kellogg Eye Center – Cataract website. REF2014MLT0034.
10. Johnson & Johnson Enterprise Business Review. December 2023
11. DOF2023CT4011 - Simulations of visual symptoms under defocus for TECNIS PureSee™ IOL. 29 March 2023.
12. DOF2023CT4043 - Clinical Investigation of the TECNIS™ Intraocular Lens, Models C1V000and C2V000. PATIENT SATISFACTION OUTCOMES. 18 July 2023.